Chongqing Pharmaceutical Research Institute was founded in 1950 andused to be a leading public institution fully dedicated to pharmaceutical research and development in Southwest China. 

　　In 2001, it underwent a historical event that the ownership of CPRI was converted to jointly owned　by Shanghai Fosun Pharmaceutical (Group) Co., Ltd and Chongqing Pharmaceutical (Group) Co., Ltd,whereby Chongqing Pharmaceutical Research Institute Co., Ltd was founded (hereinafter referred to as the CPRI). In September 2019, YaoPharma Co., Ltd. took full control of CPRI.